Welcome to the MSC Blog

MSC will be publishing a weekly blog full of information to help support and guide patients through their mast cell journey.  

Check it out!

Survey: RYDAPT (Midostaurin) Approved in Canada

RYDAPT (midostaurin) has been approved in Canada for persons with SM and is being reviewed to decide whether it should be included (paid for) in Canada's public drug plans.  Have your voice heard by completing this survey by August 22, 2019.

Go to survey!

Learn more about mast cell disease

A diagnosis or even a suspicion of one can often be overwhelming. Learn more about mast cell disease and begin taking an active role in your health care.

Learn More